Cardinal Health report highlights cost savings and provider confidence in biosimilars [Yahoo! Finance]
Cardinal Health (NYSE:CAH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Cardinal Health report highlights cost savings and provider confidence in biosimilars
Wells Fargo Raises Outlook on Cardinal Health (CAH), Cites Broad Business Strength [Yahoo! Finance]
$3.8 Billion Negative Pressure Wound Therapy (NPWT) Devices Market Assessment, 2030 - Featuring Solventum, Smith+Nephew, Cardinal Health, Molnlycke Health Care, ConvaTec Group and Other Key Players [Yahoo! Finance]